Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_provenance.
- NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_assertion description "[These observations suggest that increase of CSF HVA might be necessary for clinical improvement of choreiform movement but not correlate with the degree of improvement and dopamine agonists could be useful drug for the treatment of choreiform movement which is refractory to the administration of neuroleptics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_provenance.
- NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_assertion evidence source_evidence_literature NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_provenance.
- NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_assertion SIO_000772 7938569 NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_provenance.
- NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_assertion wasDerivedFrom befree-20150227 NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_provenance.
- NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_assertion wasGeneratedBy ECO_0000203 NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP330182.RATl3elKRXeut2nJ_Oy4Qh9Bx1bKPS-KMrNRu9PjI-JNc130_provenance.